Does Europe perform too little corporate R&D? A comparison of EU and non-EU corporate R&D performance

被引:64
|
作者
Moncada-Paterno-Castello, Pietro [1 ]
Ciupagea, Constantin
Smith, Keith [2 ]
Tuebke, Alexander [1 ]
Tubbs, Mike
机构
[1] European Commiss, IPTS, Joint Res Ctr, E-41092 Seville, Spain
[2] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England
关键词
Corporate R&D investment; R&D indicators; Decomposition of R&D intensity; Firms' demographics; EU R&D deficit; INNOVATION; GROWTH;
D O I
10.1016/j.respol.2010.02.012
中图分类号
C93 [管理学];
学科分类号
12 ; 1201 ; 1202 ; 120202 ;
摘要
This paper examines whether there are significant differences in private R&D investment performance between the EU and the US and, if so, why. The study is based on data from the 2008 EU Industrial R&D Investment Scoreboard. The investigation assesses the effects of three very distinct factors that can determine the relative size of the overall R&D intensities of the two economies: these are the influence of sector composition (structural effect) vis-A-vis the intensity of R&D in each sector (intrinsic effect) and company demographics. The paper finds that the lower overall corporate R&D intensity for the EU is the result of sector specialisation (structural effect) - the US has a stronger sectoral specialisation in the high R&D intensity (especially ICT-related) sectors than the EU does, and also has a much larger population of R&D investing firms within these sectors. Since aggregate R&D indicators are so closely dependent on industrial structures, many of the debates and claims about differences in comparative R&D performance are in effect about industrial structure rather than sectoral R&D performance. These have complex policy implications that are discussed in the closing section. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:523 / 536
页数:14
相关论文
共 50 条
  • [21] The decline of science in corporate R&D
    Arora, Ashish
    Belenzon, Sharon
    Patacconi, Andrea
    STRATEGIC MANAGEMENT JOURNAL, 2018, 39 (01) : 3 - 32
  • [22] Policies to benefit from the globalization of corporate R&D: An exploratory study for EU countries
    Guimon, Jose
    TECHNOVATION, 2011, 31 (2-3) : 77 - 86
  • [23] Internationalization of corporate R&D activities and innovation performance
    Rahko, Jaana
    INDUSTRIAL AND CORPORATE CHANGE, 2016, 25 (06) : 1019 - 1038
  • [24] EU industrial R&D shrinks
    不详
    R&D MAGAZINE, 2005, 47 (01): : 11 - 11
  • [25] EU R&D on divertor components
    Merola, M
    Dänner, W
    Pick, A
    FUSION ENGINEERING AND DESIGN, 2005, 75-79 : 325 - 331
  • [26] Tritium in fusion:: R&D in the EU
    Laesser, R.
    Antipenkov, A.
    Bekris, N.
    Boccaccini, L. V.
    Caldwell-Nichols, C. J.
    Cristescu, I.
    Day, Ch.
    Gasparotto, M.
    Glugla, M.
    Dell'Orco, G.
    Gabriel, F.
    Gastaldi, O.
    Grisolia, Ch.
    Knipe, S.
    Magielsen, A. J.
    Moeslang, A.
    Murdoch, D.
    Pearce, R.
    Perevezentsev, A.
    Piazza, G.
    Poitevin, Y.
    Ricapito, I.
    Salavy, J. -F.
    Sedano, L. A.
    Zmitko, M.
    FUSION SCIENCE AND TECHNOLOGY, 2008, 54 (01) : 39 - 44
  • [27] EU pledges R&D funding
    Nuthall, Keith
    International Dyer and Finisher, 2019, (03):
  • [28] EU Increases R&D Funding
    不详
    MANUFACTURING ENGINEERING, 2009, 142 (02): : 20 - 20
  • [29] Pharmaceutical regulation in Europe and its impact on corporate R&D
    Eger, Stephan
    Mahlich, Joerg C.
    HEALTH ECONOMICS REVIEW, 2014, 4
  • [30] PHARMACEUTICAL REGULATION IN EUROPE AND ITS IMPACT ON CORPORATE R&D
    Mahlich, J.
    Eger, S.
    VALUE IN HEALTH, 2013, 16 (07) : A487 - A487